表紙
市場調査レポート

世界の小児ワクチン市場の将来動向

Global Pediatric Vaccine Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 317310
出版日 ページ情報 英文 85 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
世界の小児ワクチン市場の将来動向 Global Pediatric Vaccine Market 2014-2018
出版日: 2014年10月22日 ページ情報: 英文 85 Pages
概要

小児ワクチンは、様々な感染症(ジフテリア、インフルエンザ、肝炎、肺炎球菌/髄膜炎菌疾患など)に対する幼児・青少年向け予防接種に用いられます。米国食品医薬品局(FDA)の定義によれば、小児科の対象年齢は0〜21歳(新生児から乳児、幼児、青少年まで)となっていますが、EMA(欧州医薬品庁)の定義では0〜18歳までとなっています。世界の小児ワクチン市場の2013〜2018年の年平均成長率(CAGR)は10.86%に達する、と予測されています。

当レポートでは、全世界の小児ワクチン市場について分析し、市場の概要や構造、市場規模の動向(今後5年間の予測値)、投与経路別(経口薬/それ以外)・製品種類別・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブ・サマリー

第2章 略語集

第3章 分析範囲

  • 市場概要
  • 主な製品

第4章 市場分析の手法

  • 市場分析のプロセス
  • 分析手法

第5章 イントロダクション

第6章 市場環境

  • 市場概況
  • 市場規模とその予測
  • ファイブフォース分析

第7章 投与経路別の市場分析

  • 経口薬
  • 非経口薬

第8章 製品種類別の市場分析

  • 多糖類ワクチン
  • 結合型ワクチン

第9章 地域別の分析

  • 南北アメリカ市場
    • 市場規模とその予測
    • 米国市場
    • ラテンアメリカ市場
  • 欧州・中東・アフリカ(EMEA)地域市場
    • 市場規模とその予測
    • 欧州市場
  • アジア太平洋地域市場
    • 市場規模とその予測
    • 中国市場
    • インド市場
    • 日本市場

第10章 主要国市場

  • 米国
  • 中国
  • インド
  • 日本

第11章 購入基準

第12章 市場の成長促進要因

第13章 促進要因とその影響力

第14章 市場の課題

第15章 促進要因・課題の影響力

第16章 市場の傾向

第17章 市場動向とその影響

第18章 ベンダー環境

  • 競争シナリオ
    • 近年の主な動向
    • 企業合併・買収(M&A)
  • 市場シェア分析
    • GlaxoSmithKline
    • Sanofi
    • Pfizer
    • Merck
  • その他の著名なベンダー

第19章 主要ベンダーの分析

  • GlaxoSmithKline
    • 主要データ
    • 事業概要
    • 事業分類
    • 部門別の市場収益額(最新値)
    • 部門別の市場収益額(前年度との比較)
    • 地域別の市場収益額
    • パイプライン製品
    • 事業戦略
    • 近年の動向
    • SWOT分析
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi

第20章 その他の関連分析

図表一覧

目次
Product Code: IRTNTR4395

About Pediatric Vaccines

Pediatric vaccines are used for the immunization of children and adolescents against various infectious diseases, such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the US FDA, pediatric age ranges are classified as newborn, infant, child, and adolescent, ranging from birth to 21 years. However, the EMA classifies pediatric age range from birth to 18 years.

TechNavio's analysts forecast the Global Pediatric Vaccine market to grow at a CAGR of 10.25 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Pediatric Vaccine market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various approved vaccines.

TechNavio's report, the Global Pediatric Vaccine Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Pediatric Vaccine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi

Other Prominent Vendors

  • AstraZeneca
  • Bavarian Nordic
  • Baxter
  • Bharat Biotech
  • Bharat Immunologicals and Biologicals
  • bioCSL
  • Bio Med
  • Crucell
  • Dynavax Technologies
  • Indian Immunologicals
  • Janssen
  • Kaketsuken
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • Novartis
  • Nuron
  • Panacea Biotec
  • Serum Institute of India
  • Shenzhen Kangtai Biological Products
  • Sinovac Biotech
  • S K Chemicals
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals
  • Zydus Cadila

Market Driver

  • Inclusion in National Immunization Schedule
  • For a full, detailed list, view our report

Market Challenge

  • Inadequate Vaccine Coverage
  • For a full, detailed list, view our report

Market Trend

  • Increase in Strategic Alliances
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Route of Administration

  • 07.1. Oral
  • 07.2. Parenteral

08. Market Segmentation by Product Type

  • 08.1. Polysaccharide Vaccines
  • 08.2. Conjugate Vaccines

09. Geographical Segmentation

  • 09.1. Pediatric Vaccine Market in Americas
    • 09.1.1. Market Size and Forecast
    • 09.1.2. Pediatric Vaccine Market in US
    • 09.1.3. Pediatric Vaccine Market in Latin America
  • 09.2. Pediatric Vaccine Market in EMEA
    • 09.2.1. Market Size and Forecast
    • 09.2.2. Pediatric Vaccine Market in Europe
  • 09.3. Pediatric Vaccine Market in APAC
    • 09.3.1. Market Size and Forecast
    • 09.3.2. Pediatric Vaccine Market in China
    • 09.3.3. Pediatric Vaccine Market in India
    • 09.3.4. Pediatric Vaccine Market in Japan

10. Key Leading Countries

  • 10.1. US
  • 10.2. China
  • 10.3. India
  • 10.4. Japan

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Key News
    • 18.1.2. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2013
    • 18.2.1. GlaxoSmithKline
    • 18.2.2. Sanofi
    • 18.2.3. Pfizer
    • 18.2.4. Merck
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. GlaxoSmithKline
    • 19.1.1. Key Facts
    • 19.1.2. Business Overview
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Segmentation by Revenue 2012 and 2013
    • 19.1.5. Sales by Geography
    • 19.1.6. Pipeline Products
    • 19.1.7. Business Strategy
    • 19.1.8. Key Information
    • 19.1.9. SWOT Analysis
  • 19.2. Merck & Co. Inc.
    • 19.2.1. Key Facts
    • 19.2.2. Business Overview
    • 19.2.3. Business Segmentation by Revenue 2013
    • 19.2.4. Business Segmentation by Revenue 2012 and 2013
    • 19.2.5. Sales by Geography
    • 19.2.6. Business Strategy
    • 19.2.7. Key Developments
    • 19.2.8. SWOT Analysis
  • 19.3. Pfizer Inc.
    • 19.3.1. Key Facts
    • 19.3.2. Business Description
    • 19.3.3. Business Segmentation
    • 19.3.4. Revenue by Business Segmentation
    • 19.3.5. Revenue Comparison 2012 and 2013
    • 19.3.6. Sales by Geography
    • 19.3.7. Business Strategy
    • 19.3.8. Key Developments
    • 19.3.9. SWOT Analysis
  • 19.4. Sanofi
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Business Segmentation by Revenue 2013
    • 19.4.4. Business Segmentation by Revenue 2012 and 2013
    • 19.4.5. Geographical Segmentation by Revenue 2013
    • 19.4.6. Business Strategy
    • 19.4.7. Key Developments
    • 19.4.8. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Pediatric Vaccine Market 2013-2018 (US$ billion)
  • Exhibit 3: Global Pediatric Vaccine Market Segmentation by Route of Administration
  • Exhibit 4: Global Pediatric Vaccine Market by Route of Administration 2013
  • Exhibit 5: Global Pediatric Vaccine Market Segmentation by Product Type
  • Exhibit 6: Global Pediatric Vaccine Market Segmentation by Product Type 2013
  • Exhibit 7: Global Pediatric Vaccine Market by Geographical Segmentation 2013
  • Exhibit 8: Global Pediatric Vaccine Market by Region/Country 2013
  • Exhibit 9: Pediatric Vaccine Market in Americas by Region/Country 2013
  • Exhibit 10: Pediatric Vaccine Market in Americas by Region/Country 2018
  • Exhibit 11: Pediatric Vaccine Market in Americas 2013-2018 (US$ billion)
  • Exhibit 12: Pediatric Vaccine Market in the US 2013-2018 (US$ billion)
  • Exhibit 13: Pediatric Vaccine Market in Latin America 2013-2018 (US$ billion)
  • Exhibit 14: Pediatric Vaccine Market in EMEA by Region 2013
  • Exhibit 15: Pediatric Vaccine Market in EMEA by Region 2018
  • Exhibit 16: Pediatric Vaccine Market in EMEA 2013-2018 (US$ billion)
  • Exhibit 17: Pediatric Vaccine Market in Europe 2013-2018 (US$ billion)
  • Exhibit 18: Pediatric Vaccine Market in APAC by Region 2013
  • Exhibit 19: Pediatric Vaccine Market in APAC by Region 2018
  • Exhibit 20: Pediatric Vaccine Market in APAC 2013-2018 (US$ billion)
  • Exhibit 21: Pediatric Vaccine Market in China 2013-2018 (US$ billion)
  • Exhibit 22: Pediatric Vaccine Market in India 2013-2018 (US$ billion)
  • Exhibit 23: Pediatric Vaccine Market in Japan 2013-2018 (US$ billion)
  • Exhibit 24: Comparison of Global Vaccine Market to Global Pediatric Vaccine Market 2013
  • Exhibit 25: Global Pediatric Vaccine Market Share Analysis 2013
  • Exhibit 26: GlaxoSmithKline's Revenue 2013
  • Exhibit 27: Sanofi's Revenue 2013
  • Exhibit 28: Pfizer's Revenue 2013
  • Exhibit 29: Merck's Revenue 2013
  • Exhibit 30: GlaxoSmithKline: Business Segmentation 2013
  • Exhibit 31: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 32: GlaxoSmithKline: Sales by Geography 2013
  • Exhibit 33: GlaxoSmithKline: Pipeline Products 2013
  • Exhibit 34: Merck & Co. Inc.: Business Segmentation by Revenue 2013
  • Exhibit 35: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 36: Merck & Co. Inc.: Sales by Geography 2013
  • Exhibit 37: Pfizer Inc.: Business Segmentation
  • Exhibit 38: Pfizer Inc.: Revenue by Business Segmentation 2013
  • Exhibit 39: Pfizer Inc.: Revenue by Business Segmentation 2012 and 2013
  • Exhibit 40: Pfizer Inc.: Revenue by Geography 2013
  • Exhibit 41: Sanofi: Business Segmentation by Revenue 2013
  • Exhibit 42: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 43: Sanofi: Geographical Segmentation by Revenue 2013
Back to Top